Technical Analysis for ADXS - Advaxis Inc
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Outside Day | Range Expansion | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| Non-ADX 1,2,3,4 Bearish | Bearish Swing Setup | -2.72% | |
| Narrow Range Bar | Range Contraction | -2.72% | |
| Inside Day | Range Contraction | -2.72% | |
| Wide Bands | Range Expansion | -2.72% | |
| Oversold Stochastic | Weakness | -2.72% | |
| 180 Bearish Setup | Bearish Swing Setup | 0.00% | |
| Non-ADX 1,2,3,4 Bearish | Bearish Swing Setup | 0.00% |
Get a Trading Sidekick!
Advaxis Inc Description
Advaxis, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of proprietary Listeria monocytogenes (Lm) technology antigen delivery products in the United States. The company is developing ADXS-PSA, which is in Phase 2 clinical trials for the treatment of metastatic prostate cancer; ADXS-503 that is in Phase 1/2 clinical trials for the treatment of non-small cell lung cancer; and ADXS-504 for the treatment of prostate cancer. It is also conducting clinical studies of Lm Technology immunotherapies in the following areas of disease focused hotspot/off-the-shelf neoantigen-directed therapies; human papilloma virus-associated cancers; and prostate cancer. The company has collaborations and partnerships with Merck & Co., Inc.; OS Therapies, LLC; Aratana Therapeutics Inc.; Biocon Limited; Global BioPharma Inc.; Knight Therapeutics Inc; and others. Advaxis, Inc. was founded in 2002 and is based in Monmouth Junction, New Jersey.
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biotechnology Cancer Clinical Medicine Disease Prostate Cancer Immunotherapy Immunotherapies Non Small Cell Lung Cancer Prostvac Treatment Of Non Small Cell Lung Cancer Treatment Of Prostate Cancer Seagen
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 4.5 |
| 52 Week Low | 0.055 |
| Average Volume | 7,185 |
| 200-Day Moving Average | 2.3971 |
| 50-Day Moving Average | 1.7325 |
| 20-Day Moving Average | 1.4943 |
| 10-Day Moving Average | 1.3255 |
| Average True Range | 0.1705 |
| RSI | 39.39 |
| ADX | 28.63 |
| +DI | 19.3780 |
| -DI | 27.4469 |
| Chandelier Exit (Long, 3 ATRs) | 1.3885 |
| Chandelier Exit (Short, 3 ATRs) | 1.7115 |
| Upper Bollinger Bands | 1.8849 |
| Lower Bollinger Band | 1.1037 |
| Percent B (%b) | 0.19 |
| BandWidth | 52.2787 |
| MACD Line | -0.1151 |
| MACD Signal Line | -0.1007 |
| MACD Histogram | -0.0144 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 1.4750 | ||||
| Resistance 3 (R3) | 1.5000 | 1.4500 | 1.4375 | ||
| Resistance 2 (R2) | 1.4500 | 1.3927 | 1.4375 | 1.4250 | |
| Resistance 1 (R1) | 1.3500 | 1.3573 | 1.3250 | 1.3250 | 1.4125 |
| Pivot Point | 1.3000 | 1.3000 | 1.2875 | 1.2875 | 1.3000 |
| Support 1 (S1) | 1.2000 | 1.2427 | 1.1750 | 1.1750 | 1.0875 |
| Support 2 (S2) | 1.1500 | 1.2073 | 1.1375 | 1.0750 | |
| Support 3 (S3) | 1.0500 | 1.1500 | 1.0625 | ||
| Support 4 (S4) | 1.0250 |
